Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Leadership Roles and Activities Among Alumni Receiving Postdoctoral Fellowship Training in Cancer Prevention.

Nelson DE, Faupel-Badger JM, Izmirlian G.

J Cancer Educ. 2019 Jun;34(3):526-534. doi: 10.1007/s13187-018-1335-7.

PMID:
29492801
2.

Career Satisfaction and Perceived Salary Competitiveness among Individuals Who Completed Postdoctoral Research Training in Cancer Prevention.

Faupel-Badger JM, Nelson DE, Izmirlian G.

PLoS One. 2017 Jan 25;12(1):e0169859. doi: 10.1371/journal.pone.0169859. eCollection 2017.

3.

The hallmarks of premalignant conditions: a molecular basis for cancer prevention.

Ryan BM, Faupel-Badger JM.

Semin Oncol. 2016 Feb;43(1):22-35. doi: 10.1053/j.seminoncol.2015.09.007. Epub 2015 Sep 8. Review.

4.

Independent Association of Postdoctoral Training with Subsequent Careers in Cancer Prevention.

Faupel-Badger JM, Nelson DE, Izmirlian G, Ross KH, Raue K, Tsakraklides S, Miyaoka A, Spiegelman M.

PLoS One. 2015 Dec 14;10(12):e0144880. doi: 10.1371/journal.pone.0144880. eCollection 2015.

5.

Alumni perspectives on career preparation during a postdoctoral training program: a qualitative study.

Faupel-Badger JM, Raue K, Nelson DE, Tsakraklides S.

CBE Life Sci Educ. 2015 Mar 2;14(1):ar1. doi: 10.1187/cbe.14-06-0102. Epub 2015 Feb 11.

6.

Maternal circulating angiogenic factors in twin and singleton pregnancies.

Faupel-Badger JM, McElrath TF, Lauria M, Houghton LC, Lim KH, Parry S, Cantonwine D, Lai G, Karumanchi SA, Hoover RN, Troisi R.

Am J Obstet Gynecol. 2015 May;212(5):636.e1-8. doi: 10.1016/j.ajog.2014.11.035. Epub 2014 Nov 27.

7.

Prolactin receptor expression and breast cancer: relationships with tumor characteristics among pre- and post-menopausal women in a population-based case-control study from Poland.

Faupel-Badger JM, Duggan MA, Sherman ME, Garcia-Closas M, Yang XR, Lissowska J, Brinton LA, Peplonska B, Vonderhaar BK, Figueroa JD.

Horm Cancer. 2014 Feb;5(1):42-50. doi: 10.1007/s12672-013-0165-7. Epub 2013 Nov 19.

8.

Health disparities around the world: perspectives from the 2012 Principles and Practice of Cancer Prevention and Control course at the National Cancer Institute.

Chawla N, Kepka DL, Heckman-Stoddard BM, Horne HN, Felix AS, Luhn P, Pelser C, Barkley J, Faupel-Badger JM.

J Oncol Pract. 2013 Nov;9(6):e284-9. doi: 10.1200/JOP.2013.001129. Epub 2013 Oct 1.

9.

Preparation of human serum for prolactin measurement by multiple reaction monitoring mass spectrometry.

Waybright TJ, Xu X, Faupel-Badger JM, Xiao Z.

Methods Mol Biol. 2013;1002:195-203. doi: 10.1007/978-1-62703-360-2_16.

PMID:
23625405
10.

Outcome evaluation of the National Cancer Institute career development awards program.

Mason JL, Lei M, Faupel-Badger JM, Ginsburg EP, Seger YR, Dijoseph L, Schnell JD, Wiest JS.

J Cancer Educ. 2013 Mar;28(1):9-17. doi: 10.1007/s13187-012-0444-y.

11.

Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop.

Faupel-Badger JM, Arcaro KF, Balkam JJ, Eliassen AH, Hassiotou F, Lebrilla CB, Michels KB, Palmer JR, Schedin P, Stuebe AM, Watson CJ, Sherman ME.

J Natl Cancer Inst. 2013 Feb 6;105(3):166-74. doi: 10.1093/jnci/djs505. Epub 2012 Dec 21. Review.

12.

Enhancing a cancer prevention and control curriculum through interactive group discussions.

Forsythe LP, Gadalla SM, Hamilton JG, Heckman-Stoddard BM, Kent EE, Lai GY, Lin SW, Luhn P, Faupel-Badger JM.

J Cancer Educ. 2012 Jun;27(3):428-35. doi: 10.1007/s13187-012-0376-6.

13.

Maternal and cord steroid sex hormones, angiogenic factors, and insulin-like growth factor axis in African-American preeclamptic and uncomplicated pregnancies.

Faupel-Badger JM, Wang Y, Staff AC, Karumanchi SA, Stanczyk FZ, Pollak M, Hoover RN, Troisi R.

Cancer Causes Control. 2012 May;23(5):779-84. doi: 10.1007/s10552-012-9934-9. Epub 2012 Mar 15.

14.

The future workforce in cancer prevention: advancing discovery, research, and technology.

Newhauser WD, Scheurer ME, Faupel-Badger JM, Clague J, Weitzel J, Woods KV.

J Cancer Educ. 2012 May;27(2 Suppl):S128-35. doi: 10.1007/s13187-012-0328-1.

15.

Associations of pregnancy characteristics with maternal and cord steroid hormones, angiogenic factors, and insulin-like growth factor axis.

Faupel-Badger JM, Wang Y, Karumanchi SA, Stanczyk F, Pollak M, McElrath T, Hoover RN, Troisi R.

Cancer Causes Control. 2011 Nov;22(11):1587-95. doi: 10.1007/s10552-011-9835-3. Epub 2011 Sep 24.

16.
17.

Maternal angiogenic profile in pregnancies that remain normotensive.

Faupel-Badger JM, Staff AC, Thadhani R, Powe CE, Potischman N, Hoover RN, Troisi R.

Eur J Obstet Gynecol Reprod Biol. 2011 Oct;158(2):189-93. doi: 10.1016/j.ejogrb.2011.05.001.

18.

Cluster analysis of placental inflammatory proteins can distinguish preeclampsia from preterm labor and premature membrane rupture in singleton deliveries less than 28 weeks of gestation.

Faupel-Badger JM, Fichorova RN, Allred EN, Hecht JL, Dammann O, Leviton A, McElrath TF.

Am J Reprod Immunol. 2011 Dec;66(6):488-94. doi: 10.1111/j.1600-0897.2011.01023.x. Epub 2011 May 30.

19.

Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland.

Nyante SJ, Faupel-Badger JM, Sherman ME, Pfeiffer RM, Gaudet MM, Falk RT, Andaya AA, Lissowska J, Brinton LA, Peplonska B, Vonderhaar BK, Chanock S, Garcia-Closas M, Figueroa JD.

Breast Cancer Res. 2011 Apr 6;13(2):R42. doi: 10.1186/bcr2864.

20.

The Ninth Annual American Association of cancer research international conference on frontiers in cancer prevention research.

Xu L, Wang SS, Healey MA, Faupel-Badger JM, Wilken JA, Battaglia T, Szabo E, Mao JT, Bergan RC.

Cancer Prev Res (Phila). 2011 Apr;4(4):616-21. doi: 10.1158/1940-6207.CAPR-11-0018.

21.

Association of serum sex steroid hormone hemodilution and body mass index among healthy postmenopausal women.

Yang HP, Black A, Falk RT, Brinton LA, Potischman N, Wentzensen N, Faupel-Badger JM, Sherman ME.

Ann Epidemiol. 2011 Jun;21(6):466-71. doi: 10.1016/j.annepidem.2011.01.003. Epub 2011 Mar 23.

22.

16 kDa prolactin reduces angiogenesis, but not growth of human breast cancer tumors in vivo.

Faupel-Badger JM, Ginsburg E, Fleming JM, Susser L, Doucet T, Vonderhaar BK.

Horm Cancer. 2010 Apr;1(2):71-9. doi: 10.1007/s12672-010-0012-z.

23.

Prolactin serum levels and breast cancer: relationships with risk factors and tumour characteristics among pre- and postmenopausal women in a population-based case-control study from Poland.

Faupel-Badger JM, Sherman ME, Garcia-Closas M, Gaudet MM, Falk RT, Andaya A, Pfeiffer RM, Yang XR, Lissowska J, Brinton LA, Peplonska B, Vonderhaar BK, Figueroa JD.

Br J Cancer. 2010 Sep 28;103(7):1097-102. doi: 10.1038/sj.bjc.6605844. Epub 2010 Aug 24.

24.

A new approach to measuring estrogen exposure and metabolism in epidemiologic studies.

Ziegler RG, Faupel-Badger JM, Sue LY, Fuhrman BJ, Falk RT, Boyd-Morin J, Henderson MK, Hoover RN, Veenstra TD, Keefer LK, Xu X.

J Steroid Biochem Mol Biol. 2010 Aug;121(3-5):538-45. doi: 10.1016/j.jsbmb.2010.03.068. Epub 2010 Apr 9. Review.

25.

Comparison of liquid chromatography-tandem mass spectrometry, RIA, and ELISA methods for measurement of urinary estrogens.

Faupel-Badger JM, Fuhrman BJ, Xu X, Falk RT, Keefer LK, Veenstra TD, Hoover RN, Ziegler RG.

Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):292-300. doi: 10.1158/1055-9965.EPI-09-0643.

26.

Anthropometric correlates of insulin-like growth factor 1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels by race/ethnicity and gender.

Faupel-Badger JM, Berrigan D, Ballard-Barbash R, Potischman N.

Ann Epidemiol. 2009 Dec;19(12):841-9. doi: 10.1016/j.annepidem.2009.08.005.

27.

Pregnancy weight gain is not associated with maternal or mixed umbilical cord estrogen and androgen concentrations.

Faupel-Badger JM, Hoover RN, Potischman N, Roberts JM, Troisi R.

Cancer Causes Control. 2009 Mar;20(2):263-7. doi: 10.1007/s10552-008-9235-5. Epub 2008 Oct 1.

28.

Lack of association between serum levels of 25-hydroxyvitamin D and the subsequent risk of prostate cancer in Finnish men.

Faupel-Badger JM, Diaw L, Albanes D, Virtamo J, Woodson K, Tangrea JA.

Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2784-6. No abstract available.

29.

Association of IL-10 polymorphisms with prostate cancer risk and grade of disease.

Faupel-Badger JM, Kidd LC, Albanes D, Virtamo J, Woodson K, Tangrea JA.

Cancer Causes Control. 2008 Mar;19(2):119-24. Epub 2007 Nov 13.

PMID:
17999153
30.

Plasma volume expansion in pregnancy: implications for biomarkers in population studies.

Faupel-Badger JM, Hsieh CC, Troisi R, Lagiou P, Potischman N.

Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1720-3.

31.

Effects of raloxifene on circulating prolactin and estradiol levels in premenopausal women at high risk for developing breast cancer.

Faupel-Badger JM, Prindiville SA, Venzon D, Vonderhaar BK, Zujewski JA, Eng-Wong J.

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1153-8.

32.

Grb2 regulation of the actin-based cytoskeleton is required for ligand-independent EGF receptor-mediated oncogenesis.

Boerner JL, Danielsen AJ, Lovejoy CA, Wang Z, Juneja SC, Faupel-Badger JM, Darce JR, Maihle NJ.

Oncogene. 2003 Oct 2;22(43):6679-89.

PMID:
14555981
33.

EGF/ErbB receptor family in ovarian cancer.

Maihle NJ, Baron AT, Barrette BA, Boardman CH, Christensen TA, Cora EM, Faupel-Badger JM, Greenwood T, Juneja SC, Lafky JM, Lee H, Reiter JL, Podratz KC.

Cancer Treat Res. 2002;107:247-58. Review.

PMID:
11775453

Supplemental Content

Loading ...
Support Center